You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 14, Issue 18

September-2 2022 - 201 articles

Cover Story: Ovarian cancer is treated with cytoreductive surgery to remove all visible cancer, in addition to platinum chemotherapy. Ultra-radical surgery, i.e., surgery involving upper abdominal organs, e.g., splenectomy, diaphragm resection, and bowel surgery, achieves this goal even when cancer has spread widely across the abdominal cavity. We analyzed cancer registry data to identify whether cancer centres practicing ultra-radical surgery have better survival than those who practice less radical surgery, including every patient with advanced ovarian cancer in the catchment of 11 UK cancer centres. We found that centres practicing ultra-radical surgery have better median survival than those who do not, even after adjusting for age and deprivation. The strength of the study is the population-based nature of the data. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (201)

  • Review
  • Open Access
28 Citations
6,574 Views
25 Pages

Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs

  • Manuel Gámez-Chiachio,
  • David Sarrió and
  • Gema Moreno-Bueno

19 September 2022

The prognosis and quality of life of HER2 breast cancer patients have significantly improved due to the crucial clinical benefit of various anti-HER2 targeted therapies. However, HER2 tumors can possess or develop several resistance mechanisms to the...

  • Article
  • Open Access
1 Citations
3,275 Views
18 Pages

Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome

  • Felix Ruoff,
  • Nicolas Kersten,
  • Nicole Anderle,
  • Sandra Jerbi,
  • Aaron Stahl,
  • André Koch,
  • Annette Staebler,
  • Andreas Hartkopf,
  • Sara Y. Brucker and
  • Markus Hahn
  • + 3 authors

19 September 2022

In cancer, the complex interplay between tumor cells and the tumor microenvironment results in the modulation of signaling processes. By assessing the expression of a multitude of proteins and protein variants in cancer tissue, wide-ranging informati...

  • Article
  • Open Access
5 Citations
5,393 Views
18 Pages

Splicing Analysis of 16 PALB2 ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants

  • Alberto Valenzuela-Palomo,
  • Lara Sanoguera-Miralles,
  • Elena Bueno-Martínez,
  • Ada Esteban-Sánchez,
  • Inés Llinares-Burguet,
  • Alicia García-Álvarez,
  • Pedro Pérez-Segura,
  • Susana Gómez-Barrero,
  • Miguel de la Hoya and
  • Eladio A. Velasco-Sampedro

19 September 2022

PALB2 loss-of-function variants are associated with significant increased risk of breast cancer as well as other types of tumors. Likewise, splicing disruptions are a common mechanism of disease susceptibility. Indeed, we previously showed, by minige...

  • Article
  • Open Access
8 Citations
6,196 Views
20 Pages

RNA-seq and ChIP-seq Identification of Unique and Overlapping Targets of GLI Transcription Factors in Melanoma Cell Lines

  • Matea Kurtović,
  • Nikolina Piteša,
  • Nenad Bartoniček,
  • Petar Ozretić,
  • Vesna Musani,
  • Josipa Čonkaš,
  • Tina Petrić,
  • Cecile King and
  • Maja Sabol

19 September 2022

Background: Despite significant progress in therapy, melanoma still has a rising incidence worldwide, and novel treatment strategies are needed. Recently, researchers have recognized the involvement of the Hedgehog-GLI (HH-GLI) signaling pathway in m...

  • Review
  • Open Access
70 Citations
23,633 Views
31 Pages

A Review on Annona muricata and Its Anticancer Activity

  • Suganya Ilango,
  • Dipak Kumar Sahoo,
  • Biswaranjan Paital,
  • Kavibharathi Kathirvel,
  • Jerrina Issac Gabriel,
  • Kalyani Subramaniam,
  • Priyanka Jayachandran,
  • Rajendra Kumar Dash,
  • Akshaya Kumar Hati and
  • Tapas Ranjan Behera
  • + 2 authors

19 September 2022

The ongoing rise in the number of cancer cases raises concerns regarding the efficacy of the various treatment methods that are currently available. Consequently, patients are looking for alternatives to traditional cancer treatments such as surgery,...

  • Article
  • Open Access
12 Citations
3,222 Views
17 Pages

A Selective Histone Deacetylase Inhibitor Induces Autophagy and Cell Death via SCNN1A Downregulation in Glioblastoma Cells

  • Hui Hua Chang,
  • Yao-Yuan Chang,
  • Bing-Chen Tsai,
  • Li-Jyun Chen,
  • An-Chi Chang,
  • Jian-Ying Chuang,
  • Po-Wu Gean and
  • Yuan-Shuo Hsueh

19 September 2022

Glioblastoma multiforme (GBM) is a grade IV, highly malignant brain tumor. Because of the heterogeneity of GBM, a multitarget drug is a rational strategy for GBM treatment. Histone deacetylase inhibitors (HDACis) regulate the expression of numerous g...

  • Review
  • Open Access
22 Citations
4,849 Views
20 Pages

MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development

  • Wen (Jess) Li,
  • Xiaozhuo Liu,
  • Emily M. Dougherty and
  • Dean G. Tang

19 September 2022

Prostate cancer (PCa) is a highly heterogeneous disease and typically presents with multiple distinct cancer foci. Heterogeneity in androgen receptor (AR) expression levels in PCa has been observed for decades, from untreated tumors to castration-res...

  • Review
  • Open Access
8 Citations
4,220 Views
25 Pages

Emerging Roles of TRIM Family Proteins in Gliomas Pathogenesis

  • Angeliki-Ioanna Giannopoulou,
  • Charalampos Xanthopoulos,
  • Christina Piperi and
  • Efterpi Kostareli

19 September 2022

Gliomas encompass a vast category of CNS tumors affecting both adults and children. Treatment and diagnosis are often impeded due to intratumor heterogeneity and the aggressive nature of the more malignant forms. It is therefore essential to elucidat...

  • Article
  • Open Access
7 Citations
3,075 Views
24 Pages

19 September 2022

Relapsed, recurrent, chemotherapy-resistant high-grade serous ovarian carcinoma is the deadliest stage of this disease. Expression of microtubule-associated protein tau (tau) has been linked to resistance to paclitaxel treatment. Here, I used models...

  • Article
  • Open Access
6 Citations
3,879 Views
12 Pages

19 September 2022

Deep convolutional neural network (CNN) helped enhance image quality of cone-beam computed tomography (CBCT) by generating synthetic CT. Most of the previous works, however, trained network by intensity-based loss functions, possibly undermining to p...

of 21

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694